Tonix Pharmaceuticals Presented Data On Its Horsepox-based Live Virus Vaccine Platform In An Oral Presentation At The World Vaccine Congress Europe; Preclinical Data Demonstrate Attenuation Of Tnx‐801 Compared To Modern Vaccinia Vaccines
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals presented preclinical data on its horsepox-based live virus vaccine platform at the World Vaccine Congress Europe. The data demonstrated the attenuation of TNX-801 compared to modern vaccinia vaccines.
October 19, 2023 | 11:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tonix Pharmaceuticals' presentation of positive preclinical data on its horsepox-based vaccine platform could potentially boost investor confidence and the company's stock price.
The presentation of positive preclinical data on a company's product, especially at a significant event like the World Vaccine Congress Europe, generally boosts investor confidence in the company. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100